Moderna Apr 20, 2026 Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNEXSPIKE - Fierce Pharma
Moderna Apr 20, 2026 Is It Too Late To Consider Moderna (MRNA) After A 114% One Year Surge? - simplywall.st
Moderna Apr 19, 2026 Moderna’s mRNA Melanoma Data And Fast Track Status Shape Oncology Story - Yahoo Finance
Moderna Apr 17, 2026 Updated: Kailera's shares climb after overtaking Moderna's IPO record with $625M raise - FirstWord Pharma